Seroatlas · Human Serome Atlas

ACADM

Medium-chain specific acyl-CoA dehydrogenase, mitochondrial

Also known as: ACAD1, ACADM_HUMAN, MCAD, MCADH

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P11310
Gene
ACADM
Ensembl
ENSG00000117054
Chromosome
1
Canonical length
421 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria,Calyx,Principal piece
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Defects in this gene cause medium-chain acyl-CoA dehydrogenase deficiency, a disease characterized by hepatic dysfunction, fasting hypoglycemia, and encephalopathy, which can result in infantile death. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

421 residues, UniProt reviewed canonical sequence.

>P11310|ACADM
     1  MAAGFGRCCR VLRSISRFHW RSQHTKANRQ REPGLGFSFE FTEQQKEFQA TARKFAREEI
    61  IPVAAEYDKT GEYPVPLIRR AWELGLMNTH IPENCGGLGL GTFDACLISE ELAYGCTGVQ
   121  TAIEGNSLGQ MPIIIAGNDQ QKKKYLGRMT EEPLMCAYCV TEPGAGSDVA GIKTKAEKKG
   181  DEYIINGQKM WITNGGKANW YFLLARSDPD PKAPANKAFT GFIVEADTPG IQIGRKELNM
   241  GQRCSDTRGI VFEDVKVPKE NVLIGDGAGF KVAMGAFDKT RPVVAAGAVG LAQRALDEAT
   301  KYALERKTFG KLLVEHQAIS FMLAEMAMKV ELARMSYQRA AWEVDSGRRN TYYASIAKAF
   361  AGDIANQLAT DAVQILGGNG FNTEYPVEKL MRDAKIYQIY EGTSQIQRLI VAREHIDKYK
   421  N

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ACADM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
446 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 446 nTPM
  • skeletal muscle: 357 nTPM
  • liver: 344 nTPM
  • kidney: 277 nTPM
  • heart muscle: 204 nTPM
  • duodenum: 98 nTPM

Single-cell type

  • esophageal apical cells: 740 nCPM
  • hepatocytes: 338 nCPM
  • parietal cells: 317 nCPM
  • myonuclei: 247 nCPM
  • proximal tubule cells: 108 nCPM
  • enterocytes: 108 nCPM

Immune cell

  • memory B-cell: 41 nTPM
  • MAIT T-cell: 27 nTPM
  • NK-cell: 25 nTPM
  • naive B-cell: 25 nTPM
  • naive CD8 T-cell: 24 nTPM
  • plasmacytoid DC: 23 nTPM

Brain region

  • choroid plexus: 16 nTPM
  • midbrain: 6.7 nTPM
  • medulla oblongata: 6.6 nTPM
  • cerebral cortex: 5.9 nTPM
  • cerebellum: 5.5 nTPM
  • spinal cord: 4.6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ACADM.

Disease | AllUniProt

Conditions ACADM is implicated in, by any mechanism.

Disease | GeneticClinVar

374 pathogenic / likely-pathogenic of 1,075 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.15
gnomAD pLI
0
gnomAD missense Z
0.54
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ACADM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ACADM as an antibody target. Whether an autoantibody or antibody against ACADM could matter depends on whether native ACADM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ACADM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ACADM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ACADM. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...